Government of India on February 3, 2020 released the Live attenuated Classical Swine Fever Vaccine (IVRI-CSF-BS) Technology developed by ICAR -Indian Veterinary Research Institute (IVRI), Izatnagar.
About Classical Swine Fever
CSF is one of the most important diseases of pigs causing high mortality with annual loss of approx. Rs.4.299 billion.
A lapinized CSF vaccine (Weybridge strain, UK) is being used in India since 1964 for controlling the disease.The vaccine is produced by sacrificing large numbers of rabbits for each batch.
In order to do away sacrificing of rabbits and increase the productivity, IVRI had earlier developed a cell culture CSF vaccine by adapting the lapinized vaccine virus in cell culture. The technology has been transferred to M/s Indian Immunologicals, Hyderabad and Government of Punjab during 2016 and 2018, respectively.
The vaccine would be the best choice for use in the CSF Control Programme (CSF-CP) already launched by DAHD (CSF-CP).
The new vaccine has been developed by a team of IVRI scientists consisting of Dr Pronab Dhar, Dr Ashok Kumar Tiwari, Dr M Manu, Dr Vikramaditya Upmanyu, Dr Richa Pachauri and Dr Raj Kumar Singh and a patent application has already been submitted for the new invention.
